Corline Biomedical AB (STO:CLBIO)
Sweden
· Delayed Price · Currency is SEK 15.65
-0.25 (-1.57%)
Mar 9, 2026, 5:29 PM CET
Corline Biomedical AB Revenue
In the year 2025, Corline Biomedical AB had annual revenue of 8.59M SEK, down -50.29%. Corline Biomedical AB had revenue of 2.15M in the quarter ending December 31, 2025, a decrease of -12.19%.
Revenue
8.59M
Revenue Growth
-50.29%
P/S Ratio
46.69
Revenue / Employee
715.50K
Employees
12
Market Cap
400.85M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 8.59M | -8.69M | -50.29% |
| Dec 31, 2024 | 17.27M | -18.25M | -51.37% |
| Dec 31, 2023 | 35.52M | 2.93M | 8.98% |
| Dec 31, 2022 | 32.59M | 15.40M | 89.55% |
| Dec 31, 2021 | 17.19M | 2.12M | 14.05% |
| Dec 31, 2020 | Pro | Pro | Pro |
| Dec 31, 2019 | Pro | Pro | Pro |
| Dec 31, 2018 | Pro | Pro | Pro |
| Dec 31, 2017 | Pro | Pro | Pro |
| Dec 31, 2016 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Oncopeptides AB | 71.12M |
| Elicera Therapeutics AB | 10.86M |
| Bio-Works Technologies AB | 63.11M |
| FluoGuide | 318.79K |
| Lipum AB | 1.93M |
| Mendus AB | -1.44M |
| Infant Bacterial Therapeutics AB | -1.00K |
| Intervacc AB | 20.09M |